A Bayesian network meta‐analysis of ALK inhibitor treatments in patients with ALK‐positive non‐small cell lung cancer

OBJECTIVE: To date, no direct comparisons have compared the effectiveness of all ALK inhibitors (ALKis) against ALK‐positive non‐small cell lung cancer (NSCLC). The aim of the present study was to investigate the efficacy and safety of ALKis in ALK‐positive NSCLC. METHODS: The effectiveness of ALKis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Bei, Jiang, Hong, Yang, Wenjuan, Li, Ying, Liang, Bingqing, Zhu, Jun, Chen, Nanmei, Chen, Miao, Zhang, Meiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469807/
https://www.ncbi.nlm.nih.gov/pubmed/37334877
http://dx.doi.org/10.1002/cam4.6241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469807/
https://www.ncbi.nlm.nih.gov/pubmed/37334877
http://dx.doi.org/10.1002/cam4.6241

Ejemplares similares